18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response
Top Cited Papers
Open Access
- 12 January 2009
- journal article
- review article
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 50 (1) , 88-99
- https://doi.org/10.2967/jnumed.108.054205
Abstract
Multimodality imaging, as represented by its greatest exponent, PET/CT, has a firm place in the evaluation of a patient presenting with cancer. With 18F-FDG, PET/CT is rapidly becoming the key investigative tool for the staging and assessment of cancer recurrence. In the last 5 y, PET/CT has also gained widespread acceptance as a key tool used to demonstrate early response to intervention and therapy. In this setting, a major clinical need is being addressed with 18F-FDG PET/CT, because of its inherent ability to demonstrate (before other markers of response) if disease modification has occurred. This review presents available evidence to this effect.Keywords
This publication has 64 references indexed in Scilit:
- What does a National Health Service mean in the 21st century?The Lancet, 2008
- Impact of Positron Emission Tomography/Computed Tomography and Positron Emission Tomography (PET) Alone on Expected Management of Patients With Cancer: Initial Results From the National Oncologic PET RegistryJournal of Clinical Oncology, 2008
- Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga‐DOTATATE (DOTA‐DPhe1,Tyr3‐octreotate) and 18F‐FDGCancer, 2008
- Non-[18F]FDG PET in clinical oncologyThe Lancet Oncology, 2007
- We Should Desist Using RECIST, at Least in GISTJournal of Clinical Oncology, 2007
- Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in LymphomaJournal of Clinical Oncology, 2007
- Positron-Emission Tomography and Assessment of Cancer TherapyNew England Journal of Medicine, 2006
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's LymphomasJournal of Clinical Oncology, 1999
- The changing classification of non-Hodgkin's lymphomasCA: A Cancer Journal for Clinicians, 1997